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S U M M A R Y
Mucormycosis is a rare but potentially lethal complication of liver transplantation. Most reported cases
have involved rhinocerebral, pulmonary, gastrointestinal, or disseminated forms. We present herein the
case of a 61-year-old male patient with hepatocellular carcinoma who developed isolated penile
mucormycosis after orthotopic liver transplantation. Such a case has not been reported in the literature
to date. Early diagnosis and timely surgical intervention combined with comprehensive treatment are
the key factors for improving the survival rate in patients with mucormycosis.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Mucormycosis is an extremely rare, but potentially life-
threatening fungal infection, which occurs in 0.4% to 16.0% of
solid organ transplantation (SOT) recipients and results in high
mortality rates.1 It is caused by species of the order Mucorales, and
those most often implicated include Rhizopus, Rhizomucor,
Cunninghamella, and Mucor. An increasing number of transplant-
associated mucormycosis cases have been reported over recent
decades. Despite aggressive surgical debridement and appropriate
antifungal treatment, the mortality remains high and virtually
unchanged since the 1960s.2 Mucormycosis can manifest with
different clinical presentations, particularly in SOT recipients,
among whom the most common type of infection is paranasal
sinus (39%), followed by pulmonary (24%), cutaneous (19%),
cerebral (9%), and gastrointestinal (7%) forms; other miscellaneous
forms are extremely rare.3 We describe the ﬁrst case of penile
mucormycosis, occurring following liver transplantation in a
patient with hepatocellular carcinoma. He was treated successfully
with surgical debridement, antifungal therapy, and temporary
withdrawal of immunosuppressants.* Corresponding author. Tel.: +86 571 87236570; fax: +86 571 87236466.
E-mail address: shusenzheng@zju.edu.cn (S.-s. Zheng).
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).2. Case report
A-61-year-old male patient underwent a deceased donor liver
transplantation for a small hepatocellular carcinoma in a back-
ground of chronic hepatitis B-related cirrhosis. During the waiting
period, he underwent trans-arterial chemoembolization treatment
once to prevent tumor progression. The surgery was uneventful, and
the graft perfusion was normal. A bigeminy immunosuppressive
regimen (methylprednisolone, mycophenolate mofetil) with anti-
CD25 induction therapy (basiliximab) was administered, and
ﬂuconazole was given for antifungal prophylaxis. Postoperatively,
the patient developed impaired liver function and acute renal
failure; hence tacrolimus was suspended until the serum creatinine
level was below 1.24 mg/dl. In light of these problems, he received
artiﬁcial liver support therapy and continuous renal replacement
therapy (CRRT). After treatment, the liver function recovered
rapidly. Twenty days post liver transplantation, the patient’s urinary
volume increased continuously and kidney function gradually
improved; no further CRRT was required.
Surprisingly, 35 days after the operation, some deep ulcers with
irregular margins appeared at the coronary sulcus and the bottom
of his penis. However, within days, the ulcerous lesions had
noticeably increased in size and his glans penis became necrotic
and ﬂecked with black spots (Figure 1a). He had a high fever but no
pain or difﬁculty in urination. Thus, we suspected an invasive
fungal or bacterial infection of the penis. Subsequently, a biopsyciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. The patient was diagnosed with isolated penile mucormycosis and underwent surgical debridement, penectomy, and cystostomy. (a) Some deep ulcers and black
spots on the penis before the operation. (b) Cytological examination revealed tangles of large non-septated fungal hyphae consistent with mucormycosis (400). (c) Post-
operation. (d) Histology examination showed several fungal hyphae (hematoxylin–eosin staining, 400).
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broad, ribbon-like, and aseptate hyphae, suggesting mucormycosis
(Figure 1b). As a result, immunosuppressive treatment was
temporarily suspended.
Concerned about the rapid progression and high mortality of
this mold infection, surgical debridement was performed imme-
diately. During the operation, we found that the infection had
disseminated from the urethra and corpus cavernosum to the
penile root. The patient underwent a penectomy and cystostomy
(Figure 1c). Postoperatively, histopathological evaluation also
showed several fungal hyphae consistent with penile mucormy-
cosis in a background of necrotic tissue (Figure 1d).
Antifungal treatment was initiated with intravenous liposomal
amphotericin B (3 mg/kg/day) for 5 weeks and this was switched to
oral posaconazole at a dose of 800 mg/day for another 7 weeks.
During this period, the patient also struggled with pulmonary and
abdominal infections, as well as poor wound healing. Therefore, as
well as the parenteral antibiotics, vacuum-sealing drainage (VSD)
was employed, which required him to stay in bed for more than a
month. Of note, the liposomal amphotericin B regimen was lower
than the standard starting doses of 5 mg/kg/day because of his
relatively poor kidney function.
Fortunately, the patient was able to tolerate the long course of
antifungal therapy; kidney function and that of the grafted liver
remained stable after this infectious episode. The mucormycosis
was completely controlled, as seen by normalization of infection
parameters (leukocyte count and C-reactive protein). Three
months later, he was readmitted and underwent a urethroplasty.
During the surgery, an additional biopsy was performed to conﬁrm
the success of the antifungal treatment.
3. Discussion
Mucormycosis in liver transplantation recipients is an extreme-
ly rare, but life-threatening fungal infection, frequently associated
with impaired immune states. With the emergence of new
antifungal therapies, immunomodulation regimens, and combinedtreatment, the survival rate of patients with invasive fungal
infections has improved signiﬁcantly.3 This situation is, however,
different for mucormycosis. Although remarkable progress has
also been made in recent decades, the overall mortality of patients
with mucormycosis remains high because of relative delays in
diagnosis. Indeed, a delay in diagnosis of this type of infection of
more than 5 days can even be associated with a two-fold
increase in mortality.4 According to a recent multicenter TRANS-
NET study, the 12-month cumulative incidence of mucormycosis
was 0.16% in liver transplantation recipients, with a mortality
rate of approximately 40%, which appears to far exceed that of all
other invasive mold infections.2
Mucormycosis generally affects patients with known predis-
posing conditions, such as organ transplantation, uncontrolled
diabetes mellitus, neutropenia, cancer, etc.3 We could identify
several risk factors for the penile mucormycosis in this patient: he
had hepatocellular carcinoma, was post liver transplantation, had
acute renal insufﬁciency after surgery, and was taking immuno-
suppressants and steroids.
The pathogenic mechanisms of mucormycosis are not yet fully
understood, unlike those of other fungi. The hallmark of Mucorales
is angioinvasion leading to thrombosis of the invaded vessels,
which can cause tissue necrosis and prevent antifungal drugs
(amphotericin B) from reaching the site of infection.2 Therefore,
timely surgical debridement is crucial in some cases and has been
reported to be an independent prognostic factor of successful
therapy in SOT patients with mucormycosis. In terms of antifungal
therapy, liposomal amphotericin B has shown better tissue
penetration and safety than amphotericin B deoxycholate. The
use of liposomal amphotericin B has been associated with a better
prognosis in SOT recipients with Mucoraceae infections, and it is
considered as the ﬁrst-line treatment.2,4 However, the efﬁcacy of
monotherapy is always limited and given the high mortality of
mucormycosis, once infection is established, or the clinical
suspicion is high, surgical intervention combined with liposomal
amphotericin B and/or posaconazole is recommended.5 In our case,
the diagnosis of penile mucormycosis was established early and
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which helped in the rapid control of the infection; the patient
eventually recovered.
In conclusion, we have presented the ﬁrst report of isolated
penile mucormycosis occurring in a liver-transplant patient that
was treated successfully with surgery and antifungal therapy. This
case emphasizes the importance of clinical ﬁndings and biopsy as
effective methods for the early diagnosis of this infection.
Mucormycosis in unusual locations is extremely rare, but it is
important to maintain a suspicion for this infection in high-risk
patients, as this is key to early diagnosis and treatment.
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